Neil J. Lachlan

Glasgow, SCT G40SF, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trial.

Autologous macrophage therapy increases transplant-free survival in cirrhosis: Long-term follow-up of a phase 2 clinical trial.

Journal: Cell stem cell

Published: December 04, 2025

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Journal: Nature medicine

Published: June 05, 2024

Letter: improve survival in variceal bleeding in cirrhosis-place pTIPS as early as possible after index bleed. Authors' reply.

Letter: improve survival in variceal bleeding in cirrhosis-place pTIPS as early as possible after index bleed. Authors' reply.

Journal: Alimentary pharmacology & therapeutics

Published: December 08, 2022

Effect of time to pre-emptive transjugular intrahepatic portosystemic shunt on patient outcome, a UK multicentre cohort study.

Effect of time to pre-emptive transjugular intrahepatic portosystemic shunt on patient outcome, a UK multicentre cohort study.

Journal: Alimentary pharmacology & therapeutics

Published: April 07, 2022

Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH).

Study protocol: a multicentre, open-label, parallel-group, phase 2, randomised controlled trial of autologous macrophage therapy for liver cirrhosis (MATCH).

Journal: BMJ open

Published: November 09, 2021

Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding.

Randomised clinical trial: standard of care versus early-transjugular intrahepatic porto-systemic shunt (TIPSS) in patients with cirrhosis and oesophageal variceal bleeding.

Journal: Alimentary pharmacology & therapeutics

Published: February 09, 2020

Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography.

Assessment of Haemodynamic Response to Nonselective Beta-Blockers in Portal Hypertension by Phase-Contrast Magnetic Resonance Angiography.

Journal: BioMed research international

Published: February 09, 2017

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.

Serelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.

Journal: PLoS medicine

Published: September 09, 2016

Editorial: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention.

Editorial: spontaneous bacterial peritonitis--bacteriology, diagnosis, treatment, risk factors and prevention.

Journal: Alimentary pharmacology & therapeutics

Published: May 14, 2015

Utility of 3-dimensional image reconstruction in the diagnosis of small-bowel masses in capsule endoscopy (with video).

Utility of 3-dimensional image reconstruction in the diagnosis of small-bowel masses in capsule endoscopy (with video).

Journal: Gastrointestinal endoscopy

Published: January 13, 2014

Anticoagulation for cirrhotic portal vein thrombosis: bold, brave, and possibly beneficial.

Anticoagulation for cirrhotic portal vein thrombosis: bold, brave, and possibly beneficial.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: March 14, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026